期刊文献+

98例初诊多发性骨髓瘤实验室检查及临床分析 被引量:2

下载PDF
导出
摘要 目的总结初诊多发性骨髓瘤(MM)的有关实验室检查和临床表现的特点。方法对98例初诊MM患者实验室资料和临床表现作回顾性分析。结果 (1)MM起病以骨痛和贫血最多见,IgG和IgA是最常见的免疫分型,占全部MM的82.5%。(2)本病起病隐匿,临床表现多样化,容易误诊。(3)大多异常的实验室检查结果无明显特异性。结论临床表现结合实验室相关指标检查,能够提高多发性骨髓瘤诊断的准确性,为临床诊断提供可靠依据。
出处 《检验医学与临床》 CAS 2010年第23期2615-2616,共2页 Laboratory Medicine and Clinic
  • 相关文献

参考文献5

二级参考文献16

  • 1李娟.多发性骨髓瘤诊治新进展[J].实用医学杂志,2005,21(3):225-229. 被引量:15
  • 2穆攀伟,穆曼娜,罗绍凯,曾龙驿.双膦酸盐药物治疗多发性骨髓瘤的进展[J].国外医学(内科学分册),2002,29(2):50-52. 被引量:1
  • 3麦玉洁,李睿,邹德慧,王亚非,赵耀中,杨仁池,王建祥,肖志坚,韩明哲,钱林生,邱录贵.206例多发性骨髓瘤患者不同方案疗效分析[J].中华血液学杂志,2005,26(4):193-196. 被引量:37
  • 4Samson D.Criteria for evaluating disease response and prognosis in patients with multiple myeloma treated by high-dose therapy and hemopoietic stem cell transplantation.British Journal of haematology,1998,102:1115-1123.
  • 5Tricot G.Multiple myeloma and other plasma cell disorders.In:Hoffman R,et al.Hematology:Basic principles and practice.3th Edition.Harcourt Asia Churchill Livingstone,2000,P1398-1402.
  • 6Kneller A,Rasuda P,Hardan I,et al.Therapy with thalidomide in refractory multiple myeloma patients-the revival of an old drug.Br J Haematol,2000,108:391-393.
  • 7Srinivas S,Yook C,Chang V,et al.Prevalence of bone marrow CD20 positivity in patients (pts) with multiple myeloma (MM).J Clin Oncol,2001,20:2687-2689.
  • 8Treon SP,Pilarski LM,Belch AR,et al.CD20-directed serotherapy in patients with multiple myeloma: biologic considerations and therapeutic applications.J Immunother,2002,25:72-81.
  • 9Sophie BN,Bart B,Regis B,et al.Advances in biology and therapy of multiple myeloma.The American Society of Hematology 45th Annual Meeting and Exposition,2003,248-278.
  • 10Tricot G. Multiple myeloma and other plasma cell disorders. In: H offman R. Hematplogy: Basic principles and practice 3th Edition[M]. Harcourt Asia Churchill Ivingstone, 2000, 1398--1402.

共引文献31

同被引文献16

  • 1杨志钊,杨山虹,郭子文,何慧清,许晓军.本周氏蛋白电泳在M蛋白检测中价值的探讨[J].中国热带医学,2006,6(12):2180-2181. 被引量:5
  • 2杨健 苏敏 萧亚景 等.多发性骨髓瘤全身骨显像与X线检查的对比研究.中华核医学杂志,2001,21(2):102-102.
  • 3张之南.血液诊断和疗效标准[M].3版.北京.科学出版社,1988:232.
  • 4Atanackovic D, Arfsten J, Cao Y, et al.Cancer-testis antigens are com-monly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation [J].Blood,2007,109: 1103-1112.
  • 5Matsui W, Huff CA, Wang Q, et al.Characterization of clonogenic multi- pie myeloma cells [J ].Blood, 2004,103 : 2332-2336.
  • 6Grogan TM, Spier CM.The B cell immunoproliferative disorders includ- ing multiple myeloma and amyloidosis [J].In : Knowles DM, editor.Neo- plastic haematopathology.2nd ed.Philadelphia:Lippincott Williams and Wilkins ,2001 : 1557-1587.
  • 7Mahnken A,Wildbeger J Gehbauer G,et al Multid etector CT of the spine in multiple myelom a comparison withMR maging and ra diogra- phy[J] Am J of Roentgenology ,2002,78 : 1429-1436.
  • 8刘志刚,牛挺.多发性骨髓瘤诊治进展[J].肿瘤预防与治疗,2009,22(4):447-451. 被引量:7
  • 9李雪华,张曦,常春康,李晓,浦权.205例多发性骨髓瘤患者骨髓涂片与活检切片内浆细胞浸润的比较研究[J].诊断学理论与实践,2010,9(1):63-65. 被引量:2
  • 10吕亚莉.血沉在多发性骨髓瘤肾病诊断中的价值[J].现代实用医学,2010,22(3):324-325. 被引量:4

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部